期刊文献+

人胰岛素样生长因子-1基因的克隆、表达和活性检测 被引量:5

THE EXPRESSION AND ACTIVITY OF NEWLY\|CLONED HUMAN INSULIN LIKE GROWTH FACTOR GENE
原文传递
导出
摘要 目的 克隆人胰岛素样生长因子Ⅰ型 (hIGF 1) ,构建真核表达载体并进行表达及活性检测 ,为IGF 1基因治疗糖尿病奠定基础。 方法 提取胎儿肝脏总RNA ,RT PCR法扩增IGF 1cDNA片段 ,重组于pUCM T载体 ,测序正确后构建表达载体 ,转染猴肾成纤维细胞系COS 7,用原位杂交和免疫组织化学检测表达 ,收集培养上清以胰岛素刺激释放实验进行活性测定。 结果 扩增得到 710bp带有Kozak序列的IGF 1cDNA片段 ;成功构建了真核表达载体pCI neo hIGF 1;IGF 1在COS 7细胞得到了表达 ,并具有刺激胰岛素分泌的活性。 结论 新构建的载体pCI neo hIGF 1能在COS 7细胞中表达、分泌 ,且所分泌的IGF 1具有生物活性。 Objective In order to investigate the roles of hIGF\|1 in treatment of diabetes mellitus and diabetic syndromes,the gene of human insulin like growth factor type Ⅰ(IGF\|1) was cloned and constructed into eukaryotic expression vector,then the expression and activity were determined. Methods Total cellular RNA of human fetal liver was abstracted and the RT\|PCR amplification of the cDNA fragment was performed.The fragment was cloned into pUCM\|T vector and sequenced.The eukaryiotic expression vector was recombined and transfected into fibroblast cell line,COS\|7.The expression of hIGF\|1 was examined by in situ hybridization and immunohistochemistry.The effect of hIGF\|1 on cultured islet cells was observed by glucose\|stimulated insulin release assay. Results The cDNA fragment of 710bp with additional Kozak sequence was amplified by RT\|PCR.Eukaryiotic expression vector pCI\|neo/hIGF\|1 was constructed and IGF\|1 gene expressed in COS\|7.The biological activity of hIGF\|1 was proved by increasing inslin secretion from islet cells.Conclusion\ The newly constructed vector,pCI\|neo/hIGF\|1 could be transfected into COS7 cells and its expressed product showed to have the biology activity of hIGF\|1.\;[
出处 《解剖学报》 CAS CSCD 北大核心 2003年第3期306-311,共6页 Acta Anatomica Sinica
关键词 人胰岛素样生长因子-1 基因克隆 基因表达 检测 生物活性 糖尿病 hIGF\|1 Clone Expression Biological activity
  • 相关文献

参考文献13

  • 1Rinderknecht E, Humbel RE. The amino acid sequence of human insulin-like growth factor Ⅰ and its structural homology with proinsulin [J]. Biol Chem, 1978,253(8):2769-2776.
  • 2Cheethan TD, Holly JM, Clayton K, et al. The effects of repeated daily recombinant human insulin-like growth factor Ⅰ administration in adolescents with type 1 diabetes[J]. Diabet Med, 1995,12 (10): 885-892.
  • 3Gombert JM, Herbelin A,Tancrede-Bohin E, et al. Early quantitative and functional deficiency of NK1 + -like thymocytes in the NOD mouse[J].Eur J Immunol, 1996,26(12):2989-2998.
  • 4Binz K, Jollet P, Froesch P, et al. Repopulation of the atrophied thymus in diabetic rats by insulin-like growth factor Ⅰ [J]. Proc Natl Acad Sci USA, 1990,87(10) :3690-3694.
  • 5Division of Medicine, St. Thomas' Hospital, London, UK. rhIGF-Ⅰadministration reduces insulin requirements, decreases growth hormone secretion, and improves the lipid profile in adults with IDDM [J].Diabetetes, 1997,46 (9): 1453-1458.
  • 6Acerini CL, Patton CM, Savage MO, et al. Randomised placebocontrolled trial of human recombinant insulin-like growth factor Ⅰ plus intensive insulin therapy in adolescents with insulin-dependent diabetes mellitus[J]. Lancet, 1997,350(9086): 1199-1204.
  • 7Moses AC, Morrow LA, O' Brien M, et al. Insulin-like growth factor Ⅰ(rhIGF-Ⅰ) as a therapeutic agent for hyperinsulinemic insulin-resistant diabetes mellitus [J]. Diabetes Res Clin Pract, 1995,28 (Suppl): 185-194.
  • 8Bondy CA, Underwood LE, Clemmons DR, et al. Clinical uses of insulin like growth factor Ⅰ [J]. Ann Intern Med, 1994,120(7): 593-601.
  • 9Kolaczynski JW, Caro JF. Insulin-like growth factor Ⅰ therapy for diabetes mellitus[J]? Diabetes Care, 1994,17(1):92-96.
  • 10Hill DJ, Petrik J, Arany E, et al. Growth factors and the regulation of fetal growth [J]. Diabetes Care, 1998,21 (Suppl 2): 60-69.

同被引文献36

引证文献5

二级引证文献16

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部